Loading…
the sparker alert will let you know when a significant move starts with an audio alert, so You'll never miss an Opportunity.

The patent was announced via a 6-K filing on September 30, 2026.
NuCana plc announced the grant of a composition-of-matter patent for its drug candidate NUC-7738 in Europe. The announcement was made through a 6-K filing on September 30, 2026.
The granted patent provides NuCana with exclusive rights to the composition of NUC-7738 within the European market.
As of the latest data, NuCana plc has a free float of 5,714,677 shares and 4,161,971 shares outstanding.
This summary was generated by AI from public sources and may contain errors. Not financial advice. Trade at your own risk.